Addus HomeCare (ADUS) News Today

Addus HomeCare Corporation (NASDAQ: ADUS) reported a mixed third quarter: earnings beat expectations and revenue grew year over year, while revenue came in slightly below consensus. Barclays raised its price target but maintained an Underweight rating, signaling valuation concerns.

• Positive Sentiment: Q3 adjusted earnings were $1.83 per share, ahead of analysts’ estimates of about $1.78–$1.79 and up from $1.56 a year earlier. Revenue increased 7% year over year to $387.7 million. The earnings beat and continued growth may support investor sentiment. Article: Addus HomeCare Surpasses Q3 Earnings Estimates
• Positive Sentiment: A Q3 deep dive pointed to steady organic growth and the AccentCare acquisition as potential foundations for further expansion, though the headline does not provide additional deal details. Article: ADUS Q3 2026 deep dive
• Neutral Sentiment: Revenue of $387.7 million was just under analysts’ roughly $388.7 million estimate. This modest miss partially offsets the earnings beat. Article: Addus HomeCare Q3 2026 earnings results
• Negative Sentiment: Barclays raised its target from $96 to $101 but kept an Underweight rating. Its target implies about 20% downside from the cited share price, a caution that the stock may be overvalued despite the improved target. Barclays stock recommendations